Vein Graft
|
|
|
|
Vitamin D deficiency and risk of cardiovascular disease
Circulation (2008) 117; 503-11
T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf and R. S. Vasan |
|
Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry)
Am J Cardiol (2008) 101; 947-52
L. Vignali, F. Saia, A. Manari, A. Santarelli, A. Rubboli, E. Varani, G. Piovaccari, A. Menozzi, G. Percoco, A. Benassi, G. Rusticali, P. Marzaroli, P. Guastaroba, R. Grilli, A. Maresta and A. Marzocchi |
|
Local paclitaxel delivery in peripheral vascular disease
N Engl J Med (2008) 358; 2406; author reply 07
M. Schillinger and E. Minar |
|
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
Am J Cardiol (2008) 101; 63-8
T. Pucelikova, R. Mehran, A. J. Kirtane, Y. H. Kim, M. Fahy, G. Weisz, A. J. Lansky, I. Moussa, W. A. Gray, M. B. Collins, S. K. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and G. Dangas |
|
Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts
Am J Cardiol (2008) 102; 530-4
T. Okabe, J. Lindsay, A. N. Buch, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman and R. Waksman |
|
Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions
Am Heart J (2008) 156; 728-35
R. H. Mehta, E. Honeycutt, L. K. Shaw and M. H. Sketch, Jr |
|
Paclitaxel-eluting stent long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study
Am J Cardiol (2009) 103; 199-202
M. H. Jim, H. H. Ho, R. L. Ko, K. H. Yiu, C. W. Siu, C. P. Lau and W. H. Chow |
|
Local paclitaxel delivery in peripheral vascular disease
N Engl J Med (2008) 358; 2406-7; author reply 07
N. Diehm, I. Baumgartner and P. Juni |
|
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
Circulation (2009) 119; 1592-600
R. H. Boger, L. M. Sullivan, E. Schwedhelm, T. J. Wang, R. Maas, E. J. Benjamin, F. Schulze, V. Xanthakis, R. A. Benndorf and R. S. Vasan |
|
|
|
|
|
|
|